Viatris ($VTRS) announced CLO Brian Roman will cease serving as CLO effective Feb 9, 2026; he’ll remain an…
Filed with the SEC on · Summarized by InvestorsBot
Viatris ($VTRS) announced CLO Brian Roman will cease serving as CLO effective Feb 9, 2026; he’ll remain an employee through Apr 1, 2026 for transition. Eligible for separation pay = base salary + target bonus + pro rata 2026; must execute a release. ⚖️💼 #Leadership #Governance
Viatris ($VTRS) named Matthew Maletta as Chief Legal Officer effective Feb 9, 2026. Maletta served as EVP, CLO & Secretary of Endo, Inc. from 2015–2025 — signals experienced pharma legal leadership. 🚀📌 #Pharma #Leadership
8‑K filed Feb 3, 2026: transition is immediate with overlap; separation cost unspecified but aligned with peer severance. Investors should watch near‑term G&A/legal expense and continuity at $VTRS. 🔍📈 #CorporateGovernance #Viatris